<< SWOT analysis of Bayer | Murad expands its product development department >>

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

Pfizer announces IES analysis of Aromasin in breast cancer recurrence

Published on December 11, 2009 at 5:12 AM · No Comments

Pfizer today announced results from an exploratory analysis of the Intergroup Exemestane Study (IES) at a median follow-up of 91 months in estrogen-receptor positive (ER+) or estrogen-receptor unknown (ER-unknown) women that looked at breast cancer free survival (BCFS) and censored deaths that occurred prior to breast cancer relapse.

These data showed that women who switched to Aromasin® (exemestane tablets) after 2.5 years of tamoxifen experienced a 19 percent reduction in risk of breast cancer recurrence (BCFS)>

Source: Pfizer

4bfbe5e1-82e3-41b1-87d0-a6720819cb56|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Adjuvant Therapy, Aromatase Inhibitor, Arthralgia, Bone, Breast Cancer, Cancer, Creatinine, Estrogen, Hormone, Hypersensitivity, Melanoma, Nursing, Oncology, Osteoporosis, Pfizer, Tamoxifen, Thrombosis

Related posts

Letrozole reduces risk of breast cancer recurrences and death in post-menopausal womenResults from the longest-running trial comparing tamoxifen with the aromatase inhibitor letrozole sh...
Positive preliminary data from ongoing PSMA ADC phase 1 study against prostate cancerProgenics Pharmaceuticals, Inc. today reported positive preliminary data from an ongoing phase 1 stu...
FDA approves GRALISE Tablets for treatment of PHNDepomed, Inc. today announced that US FDA has approved GRALISE (gabapentin) Tablets for once-daily t...
pSivida awarded $489,000 grant under IRS Qualifying Therapeutic Discovery ProjectpSivida Corp., a leader in the development of sustained release drug delivery products for the treat...
Study provides personalized strategies to boost AIAA compliance in breast cancer patientsAromatase inhibitor-associated arthralgia (AIAA) is a major side effect in breast cancer survivors, ...
Dayton Physicians select IntrinsiQ’s chemotherapy management system for improving patient careDayton Physicians LLC, one of Ohio’s leading multi-specialty cancer treatment centers, has selected ...
Androgen replacement therapy may ward off heart damage, says studyA man's male hormones may ward off heart damage by helping vessels around the heart regenerate, sugg...
Physicians and patients underestimate promotional volume of ActonelDecision Resources, one of the world's leading research and advisory firms focusing on pharmaceutica...
CyberKnife Robotic Radiosurgery System provides pain-free, non-surgical option for patients with tumoursThe Centre hospitalier de l'Université de Montréal (CHUM), invites media representatives to discover...
Nplate receives positive opinion for marketing authorisation in EuropeAmgen has announced that the European Committee for Medicinal Products for Human Use (CHMP) has issu...
Low-density lipoprotein may contribute to vascular diseasesLow-density lipoprotein (LDL), a transporter of cholesterol, may also contribute to vascular disease...
Aggressive melanoma cells secrete Nodal - protein critical to embryo formationA Northwestern University research group has discovered that aggressive melanoma cells secrete Nodal...
Hormonal treatments reduce risk of cancer returningWomen diagnosed with breast cancer who carry a certain genetic mutation can have breast-sparing surg...
Distress caused by hot flushes seriously under-playedA study by UK researchers of over 200 breast cancer patients receiving hormone treatments such as ta...
Women in the UK most anxious about breast cancerA new survey has found that one in three British women would be willing to have both breasts removed...
New kidney test better elder mortality predictorA study at the San Francisco VA Medical Center (SFVAMC) has found that a test of kidney function tha...
New treatment for T-cell acute lymphoblastic leukaemiaIL-7, a hormone-like protein involved in cell-cell interaction, has been associated with increased s...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.